Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ontak in Advanced Ovarian Cancer
NCT00880360Phase 2Completed
- Sponsor
- UT Health San Antonio
- Start
- Feb 2007
- Primary completion
- Apr 2010
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of denileukin diftitox in epithelial ovarian cancer (EOC), Extraovarian Primary Peritoneal Carcinoma (EOPPC), fallopian tube carcinoma (PFTC), sponsored by UT Health San Antonio. Started Feb 2007; status: completed.
02
Drugs
denileukin diftitox
03
Conditions
epithelial ovarian cancer (EOC)Extraovarian Primary Peritoneal Carcinoma (EOPPC)fallopian tube carcinoma (PFTC)
Beyond the preview
Go deeper on NCT00880360.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00880360.